Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$902.69 - $993.35 $2,708 - $2,980
-3 Reduced 0.12%
2,433 $2.34 Million
Q4 2023

Feb 13, 2024

BUY
$775.18 - $881.7 $55,037 - $62,600
71 Added 3.0%
2,436 $2.14 Million
Q3 2023

Nov 14, 2023

SELL
$692.45 - $844.37 $25,620 - $31,241
-37 Reduced 1.54%
2,365 $1.95 Million
Q2 2023

Aug 09, 2023

SELL
$700.03 - $830.35 $230,309 - $273,185
-329 Reduced 12.05%
2,402 $1.73 Million
Q1 2023

May 15, 2023

BUY
$680.49 - $826.97 $190,537 - $231,551
280 Added 11.42%
2,731 $2.24 Million
Q4 2022

Feb 14, 2023

BUY
$705.89 - $766.39 $605,653 - $657,562
858 Added 53.86%
2,451 $1.77 Million
Q3 2022

Nov 10, 2022

SELL
$573.97 - $724.32 $381,690 - $481,672
-665 Reduced 29.45%
1,593 $1.1 Million
Q2 2022

Aug 11, 2022

BUY
$548.35 - $738.84 $299,947 - $404,145
547 Added 31.97%
2,258 $1.34 Million
Q1 2022

May 12, 2022

SELL
$595.12 - $698.43 $160,682 - $188,576
-270 Reduced 13.63%
1,711 $1.2 Million
Q4 2021

Feb 14, 2022

SELL
$543.48 - $670.97 $153,804 - $189,884
-283 Reduced 12.5%
1,981 $1.25 Million
Q3 2021

Nov 16, 2021

BUY
$574.03 - $680.96 $190,577 - $226,078
332 Added 17.18%
2,264 $1.37 Million
Q2 2021

Aug 13, 2021

BUY
$472.8 - $558.54 $315,357 - $372,546
667 Added 52.73%
1,932 $1.08 Million
Q1 2021

May 17, 2021

SELL
$446.73 - $548.2 $236,320 - $289,997
-529 Reduced 29.49%
1,265 $599,000
Q4 2020

Feb 17, 2021

BUY
$478.3 - $607.98 $92,790 - $117,948
194 Added 12.13%
1,794 $867,000
Q3 2020

Nov 13, 2020

BUY
$544.75 - $658.21 $70,272 - $84,909
129 Added 8.77%
1,600 $896,000
Q2 2020

Aug 13, 2020

BUY
$493.32 - $643.92 $349,270 - $455,895
708 Added 92.79%
1,471 $917,000
Q1 2020

May 08, 2020

BUY
$336.18 - $494.43 $63,201 - $92,952
188 Added 32.7%
763 $373,000
Q4 2019

Feb 10, 2020

BUY
$274.13 - $376.51 $157,624 - $216,493
575 New
575 $217,000
Q3 2017

Nov 16, 2017

SELL
$431.38 - $504.0 $178,591 - $208,656
-414 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
414
414 $203,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Cetera Advisor Networks LLC Portfolio

Follow Cetera Advisor Networks LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisor Networks LLC with notifications on news.